JESSICA OGDEN: Open Payments
NPI 1851965875 · NEWTON, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$637 in 34 payments from 7 companies in 2025. Trend: 2023 $759 · 2024 $405 · 2025 $637
Food & beverage: $637
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $263 |
| Amgen Inc. | 15 | $213 |
| GlaxoSmithKline, LLC. | 4 | $68 |
| UCB, Inc. | 2 | $31 |
| Janssen Biotech, Inc. | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Janssen Scientific Affairs, LLC | 1 | $16 |
Products named: RINVOQ, EVENITY, BENLYSTA, UPLIZNA, TREMFYA, Bimzelx, TAVNEOS, KRYSTEXXA.
Industry payments across IA — which companies pay providers there.
